The in vivo prebiotic activity of lactoferrin has been demonstrated in other similar studies, which suggest a correlation between the lactoferrin-mediated improvement of dysbiosis and the amelioration of diverse pathological conditions, including obesity, inflammation, and metabolic disorders [125,147,148]. Here, LTF is linked to metabolic disease.